Investor · Newark, DE

Kelvin Neu

Open Kelvin in the network graph →

Filings

5

SEC Form D

Connections

31

co-filers

Capital

$92.0M

across filings

Active

Apr 2013

to Aug 2020

Most-connected co-filers (31)

Paul Friedman · San Francisco, CA4 shared Krishna Vaddi · Chadds Ford, PA4 shared David P. Bonita · New York, NY4 shared Peggy C. Scherle · Wilmington, DE2 shared David C. Mauro · Wilmington, DE2 shared Juan Luengo · Newark, DE2 shared Andrew C. Combs · Wilmington, DE1 shared Brian C. Piper · Wilmington, DE1 shared Deborah C. Morosini · Wilmington, DE1 shared Christopher C. Pierce · Wilmington, DE1 shared Victor Sandor · Wilmington, DE1 shared John G. Barrie · EDINBURGH, United Kingdom1 shared Robert Weiss · New York, NY1 shared Kenneth Galbraith · San Francisco, CA1 shared Jack Obijeski · San Francisco, CA1 shared Ron Hunt · East Providence, RI1 shared H. Daniel Perez · San Francisco, CA1 shared Richard Colonno · San Francisco, CA1 shared Nathaniel Brown · San Francisco, CA1 shared Kevin B. Cashen · Lutherville, MD1 shared Scott Lessing · San Francisco, CA1 shared Leping Li · San Francisco, CA1 shared Eric Ruby · San Francisco, CA1 shared Byler Kerry · CHICAGO, IL1 shared

Recent filings (5)

Prelude Therapeutics IncAug 2020 · 23 co-filers$50.0M Prelude Therapeutics IncAug 2020 · 23 co-filers$50.0M Prelude Therapeutics IncJun 2019 · 11 co-filers$60.0M Prelude Therapeutics IncJun 2019 · 11 co-filers$60.0M Prelude Therapeutics IncAug 2018 · 9 co-filers$30.0M Prelude Therapeutics IncAug 2018 · 9 co-filers$30.0M Prelude Therapeutics Inc.Oct 2017 · 9 co-filers$12.0M Prelude Therapeutics Inc.Oct 2017 · 9 co-filers$12.0M Presidio Pharmaceuticals, Inc.Apr 2013 · 20 co-filers$15.0M Presidio Pharmaceuticals, Inc.Apr 2013 · 20 co-filers$15.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Kelvin in the interactive graph →